Page 219 - Read Online
P. 219

Page 6 of 11                                                                 Raja. Vessel Plus 2019;3:23  I  http://dx.doi.org/10.20517/2574-1209.2019.05

               reoperation, 8.6% (95% CI, 4.7%-12.6%) and 12.9% (95% CI, 7.6%-18.2%) for cardiac death, and 10.8% (95% CI,
               6.5%-15.2%) and 15.2% (95% CI, 9.8%-20.6%) for death from other causes.


                                   [27]
               Tatoulis and colleagues  in a mulitcentre analysis compared outcomes in patients who underwent TAR
               (n = 12,271) with outcomes in those who did not (n = 21,910). They determined the impact of TAR on 10-year
               all-cause late mortality by propensity score analyses in 6,232 matched pairs. The 30-day mortality was 0.8%
               (96/12,271) for TAR patients and 1.8% (398/21,910) for non-TAR patients (P < 0.001). Late mortality was 7.5%
               (918/12,271) for TAR patients and 8.9% (1,952/21,910) for non-TAR patients (P < 0.001). The mean follow-up
               time was 4.9 years. In the propensity-matched cohort, the perioperative mortality was 0.9% (53/6,232) for
               TAR patients versus 1.2% (76/6,232) for non-TAR patients (P < 0.001). Kaplan-Meier survival in the matched
               cohort at 1, 5, and 10 years was 97.2%, 91.3%, and 85.4% for TAR patients and 96.5%, 90.1%, and 81.2% for
               non-TAR patients (P < 0.001). Late mortality was 8.0% (n = 500) for TAR patients and 10.0% (n = 622) for
               non-TAR patients (P < 0.001). Stratified Cox proportional hazards models showed lower risk for all-cause late
               mortality in the TAR group (TAR:HR 0.80, 95% confidence interval 0.71 to 0.90, P < 0.001).


               A systematic review and meta-analysis of 130,305 patients from 4 smaller shorter follow-up RCTs, plus 15
               matched/adjusted and 6 unmatched/unadjusted larger longer follow-up observational studies suggested
               that TAR may improve long-term survival compared with conventional CABG by 15%-20% even when
                                            [28]
               compared with two arterial grafts .

               CONCERNS
               Single blood source
               The composite grafting technique has the disadvantage of complete reliance of the coronary bypass flow
               on the flow of the proximal IMA. Multiple clinical and experimental studies have assessed the adequacy of
                                                                                                [30]
               the IMA as the sole blood source in composite arterial grafting [29,30] . Sakaguchi and colleagues , utilizing
               positron emission tomography, demonstrated that the composite Y graft was not as efficient as independent
               grafts for increasing the coronary flow reserve soon after bypass grafting. However, most investigations
               have reported that the flow reserve of the proximal IMA is adequate as a blood source of composite grafts
                                 [31]
               in TAR. Affleck et al. , in an effort to determine the constraint posed by a single source inflow recorded
               intraoperative flow in each limb of the T graft before and after distal anastomoses in 204 patients. They
               also compared flow capacity with completion coronary flow. Free flow for the radial arterial limb was
               reported as 161 ± 81 mL/min, the IMA limb as 137 ± 57 mL/min (combined 298 ± 101 mL/min) compared
               with simultaneous limb flow of 226 ± 84 mL/min resulting in a flow restriction of 24% ± 14%. Completion
               coronary flow was 88 ± 49 mL/min for the radial artery, 60 ± 45 mL/min for the IMA, and 140 ± 70 mL/min
               for both limbs simultaneously to give a flow reserve (vs. simultaneous free flow) of 160% or 1.6. This flow
               reserve of 1.6 compares favorably with an IMA flow reserve of 1.8 at 1-month postoperatively and 1.8 for
               both the IMA T graft and the IMA/radial artery T graft at 1-week postoperatively as reported by Wendler
               and associates .
                           [32]

               Graft spasm and hypoperfusion
               Hypoperfusion syndrome, associated with a high mortality, is a recognized sequela of vasospasm of
               arterial grafts. Spasm of the proximal IMA in case of composite grafting may result in hypoperfusion of
                                                                             [30]
               the whole left coronary system and may lead to calamitous consequences . Similarly, the radial artery and
               gastroepiploic artery with an enhanced spasmodic tendency, owing to preponderance of smooth muscle,
                                                                                                        [33]
               predispose to a risk of hypoperfusion due to spasm of these vessels if used to construct a composite graft .
               In practice however, 1% to 2% of the patients undergoing composite arterial grafting experience
               perioperative hypoperfusion resulting in myocardial ischemia, infarction, low output states, or even
               extreme hypotension [33,34] . Injury to the conduit during harvest, technical errors in the anastomosis, linear
   214   215   216   217   218   219   220   221   222   223   224